Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P V Rabins

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Neurology|November 7, 2007
Vascular factors predict rate of progression in Alzheimer diseaseM M Mielke, P B Rosenberg, J Tschanz, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 4, 2008
Effects of cardiovascular medications on rate of functional decline in Alzheimer diseaseP B Rosenberg, M M Mielke, J Tschanz, et al.
International Journal of Geriatric Psychiatry|March 1, 2012
The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's diseaseP B Rosenberg, M M Mielke, D Han, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodologyL S Schneider, P N Tariot, C G Lyketsos, et al.
JAMA|October 29, 1997
Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics SocietyG W Small, P V Rabins, P P Barry, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Neurology|November 7, 2007
Vascular factors predict rate of progression in Alzheimer diseaseM M Mielke, P B Rosenberg, J Tschanz, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 4, 2008
Effects of cardiovascular medications on rate of functional decline in Alzheimer diseaseP B Rosenberg, M M Mielke, J Tschanz, et al.
International Journal of Geriatric Psychiatry|March 1, 2012
The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's diseaseP B Rosenberg, M M Mielke, D Han, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodologyL S Schneider, P N Tariot, C G Lyketsos, et al.
JAMA|October 29, 1997
Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics SocietyG W Small, P V Rabins, P P Barry, et al.
Pageof 7